Jul 14, 2025 · Kerendia is used to slow down kidney damage, and also to reduce the risk of kidney failure, cardiovascular death, heart attack, and being hospitalized for heart failure. …

Learn about KERENDIA® (finerenone), a medication for chronic kidney disease in adults with T2D and heart failure with LVEF ≥40%. See safety and full prescribing info.

Jun 12, 2024 · Kerendia blocks a receptor called the mineralocorticoid receptor (MR), which is found in your kidneys, heart, and blood vessels. This receptor can be too active in diabetes, …

Kerendia® (finerenone) is FDA approved to treat adult patients with CKD associated with T2D and heart failure with Left Ventricular Ejection Fraction (HF LVEF) ≥40%.

Nov 7, 2025 · Kerendia (Finerenone Tablets) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and …

Aug 28, 2025 · Kerendia is indicated to reduce the risk of: sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, cardiovascular death, non-fatal …

Kerendia is available as a film-coated tablet in three strengths. The 10 mg is a pink oblong tablet with “FI” on one side of tablet and “10” on the other side of tablet.

Kerendia is used for the treatment of adults with chronic kidney disease (with abnormal presence of the protein albumin in the urine) associated with type 2 diabetes.

Kerendia is available as a film-coated tablet in three strengths. The 10 mg is a pink oblong tablet with “FI” on one side of tablet and “10” on the other side of tablet.

KERENDIA is a once-daily treatment that can help slow the progression of chronic kidney disease (CKD) and lower the risk of cardiovascular complications in adults with CKD in type 2 diabetes …